Roche CEO on Illumina, DNA Sequencing, Euro Crisis

Published On: February 7th, 2012

In a wide-ranging interview, Roche Group CEO Severin Schwan discusses his company’s bid for Illumina, the future of gene-sequencing technology and what concerns him most about Europe’s debt crisis.

Read the original post:
Roche CEO on Illumina, DNA Sequencing, Euro Crisis/a>

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

Did you know:

Racial and ethnic minorities are more likely to live in heavily polluted neighborhoods and work in high-risk occupations with lower air quality. Disparities in living and working conditions play a critical role in the incidence and burden of asthma in these populations

diarress87 : FFF : football, FIFA, UEFA, Coupe du Monde, Mondial, Europe - http://t.co/secy2btu

2012-05-23T18:52:20Z - Reply - View Tweet
TWREurope : RT @IJMHQ: RT @TheA21Campaign: More than 200k women?1/4 of all women trafficked?are smuggled out of E. Europe each yr end up working as sex slaves.

2012-05-23T18:52:19Z - Reply - View Tweet
MidtownNate : RT @PaulCantor: if Flo Rida could speak other languages he would make a billion dollars this year from making regional dance songs in Europe.

2012-05-23T18:52:19Z - Reply - View Tweet
ThePrincipal : The economic growth of Europe may be sacrificed on the altar of politics. McCaughan?s thoughts from the #2012GC: http://t.co/yoQMt7nU

2012-05-23T18:52:14Z - Reply - View Tweet
TatianaMUFC : @Fino76 US is pretty fantastic. Lots to offer. Still prefer Europe though. England and Germany for me. Planning to move to NY in near future

2012-05-23T18:52:13Z - Reply - View Tweet
TheIreneGons : RT @Michelle_xx1D: I dont care if you're straight , Gay, fat, skinny , tall, short,from Africa , Asia , Europe... just Be nice and I'll love you.

2012-05-23T18:52:13Z - Reply - View Tweet
NESmallBiz : [http://t.co/LQbOQXWW Money] Treasurys march higher as stocks swoon on Europe http://t.co/LRTThiwG

2012-05-23T18:52:13Z - Reply - View Tweet

Health Blog Video: Roche CEO on the Illumina Bid
Roche CEO Severin Schwan recently sat down with the WSJ’s Jonathan Rockoff to discuss a wide range of topics — including the Swiss pharma giant’s recent bid for gene-sequencing company Illumina. Among the highlights: Schwan says Roche expects that longer-term, gene sequencing will move from the research setting into the clinical setting — but that..
A.M. Vitals: Roche Bids $5.7 Billion For Illumina
Hostile Bid For Illumina: Swiss drug maker Roche is making a $44.50 per-share hostile bid for Illumina, valuing the gene-sequencing company at $5.7 billion, the WSJ reports . Illumina has already rejected an offer of $40 per share, Roche says ..
Pacific Biosciences Speeds DNA Sequencing
Pacific Biosciences is working on a DNA sequencing process that it says will allow a person’s genome to be sequenced in under an hour for less than $100 making a future of personally tailored genetic medicine more feasible. ..
Robert Reich's Blog: The Health Care Cave-In
Many experts have long agreed that a so-called “single-payer” plan is the ideal, because competition among private insurers who pay health -care bills inevitably causes them to spend big bucks trying to find and market policies to … ..
HHS Releases Final Medical Loss Ratio Regulations
The regulations weren’t changed from those recommended by the National Association of Insurance Commissioners last month. ..
After Genetech Deal, Roche Says ‘So Long, PhRMA; Hello, BIO’
Roche’s victory in buying Genentech is turning into a loss of a long-time member for PhRMA , the big trade group for drug companies in the U.S. The Swiss drug maker says it’s dropping its membership in PhRMA as of today and will focus on working with a more specialized lobbying outfit, the Biotech Industry..

Orshe